Robert A. Michael
CEO & Chairman of the BoardMr. Robert A. Michael, C.P.A., served as Chief Operating Officer at AbbVie Inc. since June 29, 2023 until July 01, 2024 and served as its President since June 23, 2022 until July 01, 2024 also serves as its CEO and Director since July 1, 2024 and serves as its Chairman since July 01, 2025. He has been President and Director at Allergan plc since May 8, 2020. He served as Vice Chairman of AbbVie Inc. since June 23, 2022 until 2023. He had been Chief Financial Officer of AbbVie Inc. since October 19, 2018 until June 23 2022 and served as its Vice Chairman of Finance & Commercial Operations since December 2021 until June 23 2022 and was its Executive Vice President since July 2019 until December 2021. He served as a Senior Vice President at AbbVie Inc. He served as Vice President of AbbVie Inc. from 2015 to October 19, 2018 and as its Controller from March 1, 2017 to October 19, 2018. Mr. Michael served as Treasurer of AbbVie Inc. since 2015. He was an Officer of AbbVie since 2015 and served as Vice President, Controller, Commercial Operations from 2013 to 2015 and Vice President of Financial Planning & Analysis from 2012 to 2013. At Abbott Laboratories, AbbVie's former parent company, Mr. Michael served as Division Controller of Nutrition Supply Chain from 2010 to 2012. Mr. Michael joined Abbott in 1993.
Positions
- Company NameAbbVie Inc.Stock CodeABBVPositionCEO & Chairman of the BoardColleagues
- STScott T. ReentsExecutive VP & CFO
- ASAzita SalekiExecutive VP & COO
- RBRoopal B. ThakkarExecutive VP of Research & Development and Chief Scientific Officer
- JRJeffrey Ryan StewartExecutive VP & Chief Commercial Officer
- TCThomas Craig FreymanIndependent Director
- FHFrederick H. WaddellIndependent Director
- BJBrett J. HartIndependent Director
- MBMelody Boone MeyerIndependent Director
